This inventor holds 2 USPTO granted patents. Top assignees: Albert Einstein College of Medicine, Icahn School of Medicine at Mount Sinai, Other. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 514 
1 out of 537 
1 out of 834,513 Years Active: 2011-2014
Title: Khaja Farid Ahmad: Innovator in Cancer Research
Introduction
Khaja Farid Ahmad is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, Ahmad's work focuses on methods and compositions that target BCL6 repression, a critical factor in cancer progression.
Latest Patents
Ahmad's latest patents include groundbreaking methods and compositions for the inhibition of BCL6 repression. These patents provide peptides or mimetics that block corepressor binding to a BCL6 lateral groove. Additionally, they outline methods for inhibiting BCL6 repression in mammalian cells and offer potential treatments for mammals suffering from cancer.
Career Highlights
Throughout his career, Ahmad has worked at prestigious institutions, including the Albert Einstein College of Medicine. His research has been pivotal in advancing our understanding of cancer biology and developing therapeutic strategies.
Collaborations
Ahmad has collaborated with esteemed colleagues such as Ari Matthew Melnick and Jonathan D Licht. These partnerships have further enriched his research and contributed to the scientific community's knowledge of cancer treatment.
Conclusion
Khaja Farid Ahmad's innovative work in cancer research exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile